Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Cardiovascular, Blood & Acute Care
Filter     Order     Display # 
Date Item Title
17 Nov 2008 Lilly Licenses U.S. Rights for Tadalafil PAH Indication to United Therapeutics
17 Nov 2008 Freedom-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails to Meet Primary Endpoint
17 Nov 2008 ARYx Therapeutics Presents Clinical Data for ATI-5923 at American Heart Association Scientific Sessions 2008
12 Nov 2008 Tercica Announces Results from Increlex(R) Phase IIIb Study Demonstrating Dose-Dependent Height Velocity Increase in Primary IGFD Short Stature Population and Other Increlex(R) Studies at the 13th International Congress of Endocrinology Meeting
12 Nov 2008 Longest follow-up period for any new oral anticoagulant explores Pradaxa(R) (dabigatran etexilate) for stroke prevention in atrial fibrillation (AF)
12 Nov 2008 ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
12 Nov 2008 Biovitrum Extends ReFacto(R) Supply Agreement with Wyeth until December 31, 2015
11 Nov 2008 Rasilez(R), first-in-class direct renin inhibitor, provides greater reduction in high blood pressure than ACE inhibitor ramipril in patients 65 and older
11 Nov 2008 Anthera's Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients with Coronary Heart disease
10 Nov 2008 VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
10 Nov 2008 Rivaroxaban Phase II Dose-Ranging Study Demonstrates Encouraging Response Rates in Treatment of Acute Coronary Syndrome Patients
10 Nov 2008 AVI BioPharma Announces Initiation of Clinical Trial of Next Generation Drug Eluting Stent by Partner Global Therapeutics
10 Nov 2008 Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure
09 Nov 2008 CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
06 Nov 2008 Proteon Therapeutics Presents New Data on PRT-201 at the Annual Meeting of the American Society of Nephrology in Philadelphia
06 Nov 2008 FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
04 Nov 2008 Sanvar(R) (Debio 8609) for esophageal variceal bleeding - Debiopharm submits response to the FDA
03 Nov 2008 Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke prevention in Atrial Fibrillation
03 Nov 2008 ARYx Therapeutics Inc. Completes Enrollment in EmbraceAC Study -- Phase 2/3 Clinical Trial Comparing Anticoagulant ATI-5923 Against Warfarin
03 Nov 2008 Chelsea Therapeutics Reports Significant Reduction in Severity of Symptoms During Titration Phase of Pivotal Droxidopa Study in Neurogenic Orthostatic Hypotension
29 Oct 2008 Northfield Laboratories Inc. Announces Submission of BLA for PolyHeme(R)
28 Oct 2008 Gilead Announces Two-Year Clinical Data for Letairis(R) (ambrisentan) for the Treatment of Pulmonary Arterial Hypertension (WHO Group 1)
24 Oct 2008 Omrix Biopharmaceuticals Announces Patient Enrollment Will Resume In Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding
23 Oct 2008 Sciele Pharma Announces That Addrenex Pharmaceuticals Initiates Phase II Clinical Trial of ADX415 for the Treatment of Hypertension
22 Oct 2008 FDA Approves Astellas' Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
20 Oct 2008 AMAG Pharmaceuticals Receives Complete Response Letter from FDA for Ferumoxytol
17 Oct 2008 Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
15 Oct 2008 BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
15 Oct 2008 Cleveland BioLabs Doses First Healthy Volunteer in Initial Safety Study for Protectan CBLB502
14 Oct 2008 Athersys Announces Initial Patient Dosing of MultiStem(r) in Phase I Acute Myocardial Infarction Trial
14 Oct 2008 Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure
14 Oct 2008 Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
12 Oct 2008 First Heart Failure Patients Successfully Implanted with Angioblast Systems’ “Off-the-Shelf” Adult Stem Cells
10 Oct 2008 Omrix Biopharmaceuticals Provides Update On Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding
10 Oct 2008 Cinryze(TM) Receives FDA Approval for Prophylaxis Against Hereditary Angioedema Attacks
10 Oct 2008 Omrix Biopharmaceuticals Announces Interim Analysis Indicating Superiority of Fibrin Pad Versus SURGICEL in Mild to Moderate Bleeding In U.S. Phase II Clinical Trial And Provides Update On Additional Fibrin Pad Clinical Trials
10 Oct 2008 Omrix Biopharmaceuticals Announces Interim Analysis Indicating Superiority of Fibrin Pad Versus SURGICEL in Mild to Moderate Bleeding In U.S. Phase II Clinical Trial And Provides Update On Additional Fibrin Pad Clinical Trials
10 Oct 2008 Elixir Medical Corporation Licenses Myolimus(TM) From Novartis Pharma AG for Site-Specific Drug Delivery Applications
08 Oct 2008 Early data show potential for imatinib to treat life-threatening form of pulmonary artery disease
06 Oct 2008 Bayer Reports Progress in Clinical Program for Riociguat
02 Oct 2008 Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation
29 Sep 2008 ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
29 Sep 2008 FDA Continues to Review Prasugrel New Drug Application
23 Sep 2008 PolyMedix Initiates Dosing in Phase I Clinical Study of Novel Anticoagulant Antagonist Compound
23 Sep 2008 RegeneRx Enrolls First Subject in RGN-352 Phase IB Clinical Trial
23 Sep 2008 Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
17 Sep 2008 Daiichi Sankyo, Inc. Files Supplemental New Drug Application for AZOR(R) as Initial Therapy for High Blood Pressure
17 Sep 2008 China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
17 Sep 2008 Bio3 Research S.r.l. and ProtElix Inc. enter into an agreement for the development of mimic-antibody HMGB1 antagonists to prevent restenosis and atherosclerotic plaque progression
16 Sep 2008 Bayer’s Xarelto(R) Approved in Canada
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 50 of 996

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics